DRUG

CGF-Conditioned Medium

3 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for CGF-Conditioned Medium

Alzheimer 3

Mediator Outcome Score Tier Lit. status Trial
GFAP Alzheimer's disease 0.208 Mid novel signal none
GFAP cognitive impairment 0.208 Mid novel signal none
GFAP cognitive decline 0.208 Mid novel signal none

Clinical trials

0 registered trials for CGF-Conditioned Medium

Source: ClinicalTrials.gov

No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.

Search ClinicalTrials.gov →